Descriptions
Autoinhibitory domains (AIDs)
Target domain |
26-218 (CARD domains) |
Relief mechanism |
Partner binding |
Assay |
|
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

1 structures for Q53B88
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q53B88-F1 | Predicted | AlphaFoldDB |
No variants for Q53B88
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for Q53B88 |
No associated diseases with Q53B88
5 regional properties for Q53B88
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | CARD domain | 26 - 120 | IPR001315-1 |
domain | CARD domain | 134 - 218 | IPR001315-2 |
domain | NACHT nucleoside triphosphatase | 293 - 462 | IPR007111 |
domain | NOD2, winged helix domain | 546 - 587 | IPR041075 |
domain | NACHT, LRR and PYD domains-containing protein, helical domain HD2 | 603 - 757 | IPR041267 |
Functions
8 GO annotations of cellular component
Name | Definition |
---|---|
basolateral plasma membrane | The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
cell surface | The external part of the cell wall and/or plasma membrane. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytoskeleton | A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
protein-containing complex | A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. |
vesicle | Any small, fluid-filled, spherical organelle enclosed by membrane. |
6 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
CARD domain binding | Binding to a CARD (N-terminal caspase recruitment) domain, a protein-protein interaction domain that belongs to the death domain-fold superfamily. These protein molecule families are similar in structure with each consisting of six or seven anti-parallel alpha-helices that form highly specific homophilic interactions between signaling partners. CARD exists in the N-terminal prodomains of several caspases and in apoptosis-regulatory proteins and mediates the assembly of CARD-containing proteins that participate in activation or suppression of CARD carrying members of the caspase family. |
enzyme binding | Binding to an enzyme, a protein with catalytic activity. |
muramyl dipeptide binding | Interacting selectively and non-covalently, in a non-covalent manner, with muramyl dipeptide; muramyl dipeptide is derived from peptidoglycan. |
peptidoglycan binding | Interacting selectively and non-covalently, in a non-covalent manner, with peptidoglycan, any of a class of glycoconjugates found in bacterial cell walls. |
protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
16 GO annotations of biological process
Name | Definition |
---|---|
cellular response to lipopolysaccharide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
cellular response to muramyl dipeptide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muramyl dipeptide stimulus. Muramyl dipeptide is derived from peptidoglycan. |
defense response to bacterium | Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism. |
detection of bacterium | The series of events in which a stimulus from a bacterium is received and converted into a molecular signal. |
detection of muramyl dipeptide | The series of events in which a muramyl dipeptide stimulus is received by a cell and converted into a molecular signal. Muramyl dipeptide is derived from peptidoglycan. |
innate immune response | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
intracellular signal transduction | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
nucleotide-binding oligomerization domain containing 2 signaling pathway | The series of molecular signals initiated by the binding of a ligand (such as a bacterial peptidoglycan) to a cytoplasmic nucleotide-binding oligomerization domain containing 2 (NOD2) protein receptor, and ending with regulation of a downstream cellular process. |
positive regulation of cytokine production involved in immune response | Any process that activates or increases the frequency, rate, or extent of cytokine production that contributes to an immune response. |
positive regulation of I-kappaB kinase/NF-kappaB signaling | Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling. |
positive regulation of interleukin-1 beta production | Any process that activates or increases the frequency, rate, or extent of interleukin-1 beta production. |
positive regulation of interleukin-17 production | Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines. |
positive regulation of NF-kappaB transcription factor activity | Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
regulation of apoptotic process | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
response to muramyl dipeptide | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muramyl dipeptide stimulus. Muramyl dipeptide is derived from peptidoglycan. |
No homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
No homologous proteins |
10 | 20 | 30 | 40 | 50 | 60 |
MGEEGGSVSH | DEEERASVLL | GQYLGCEMCS | QEAFQAQRSQ | LVELLVSGSL | EGFESVLDWL |
70 | 80 | 90 | 100 | 110 | 120 |
LSWEVLSWED | YEGFHLLGQP | LSHLARRLLD | TVWNKGTWAC | QKLIAAAQEA | QADSQSPKLH |
130 | 140 | 150 | 160 | 170 | 180 |
GCWDPHSLHP | ARDLQSHRPA | IVRRLHSHVE | GVLDLAWERG | FVSQYECDEI | RLPIFTPSQR |
190 | 200 | 210 | 220 | 230 | 240 |
ARRLLDLATV | KANGLAAFLL | QHVQELPVPL | ALPLEAATCR | KYMAKLRTTV | SAQSRFLSTY |
250 | 260 | 270 | 280 | 290 | 300 |
DGAETLCLED | IYTENVLEVW | ADVGTAGPPP | KSPATLGLEE | LFSTPGHLND | DADTVLVVGE |
310 | 320 | 330 | 340 | 350 | 360 |
AGSGKSTLLQ | RLHLLWAAGR | DFQEFLFVFP | FSCRQLQCMA | KPLSVRTLLF | EHCCWPDVGQ |
370 | 380 | 390 | 400 | 410 | 420 |
EDIFQLLLDH | PDRVLLTFDG | FDEFKFRFTD | RERHCSPTDP | TSVQTLLFNL | LQGNLLKNAR |
430 | 440 | 450 | 460 | 470 | 480 |
KVVTSRPAAV | SAFLRKYIRT | EFNLKGFSEQ | GIELYLRKRH | REPGVADRLI | RLLQATSALH |
490 | 500 | 510 | 520 | 530 | 540 |
GLCHLPVFSW | MVSKCHQELL | LQEGGSPKTT | TDMYLLILQH | FLLHAIPPDS | ASQGLGPSLL |
550 | 560 | 570 | 580 | 590 | 600 |
RGRLPTLLHL | GRLALWGLGM | CCYVFSAQQL | QAAQVSPDDI | SLGFLVRAKG | VVPGSTAPLE |
610 | 620 | 630 | 640 | 650 | 660 |
FLHITFQCFF | AAFYLALSAD | VPPALLRHLF | NCGRPGNSPV | ARLLPTLCIQ | GSEGKDSSVA |
670 | 680 | 690 | 700 | 710 | 720 |
ALLQKAEPHN | LQITAAFLAG | LLSREHWGLL | AECQTSEKAL | LRRQACARWC | LARSLRKHFH |
730 | 740 | 750 | 760 | 770 | 780 |
SIPPAAPGEA | KSMHAMPGFI | WLIRSLYEMQ | EERLARKAAR | GLNVGHLKLT | FCSVGPAECA |
790 | 800 | 810 | 820 | 830 | 840 |
ALAFVLQHLR | RPVALQLDYN | SVGDIGVEQL | LPCLGVCKAL | YLRDNNISDR | GICKLIECAL |
850 | 860 | 870 | 880 | 890 | 900 |
HCEQLQKLVL | FNNKLTDGCA | HSMAKLLACR | QNFLALRLGN | NHITPAGAQV | LAEGLRGNTS |
910 | 920 | 930 | 940 | 950 | 960 |
LQFLGFWGNR | VGDEGAQALA | EALGDHQSLR | WLSLVGNNIG | SVGAQALALM | LAKNVMLEEL |
970 | 980 | 990 | 1000 | 1010 | 1020 |
CLEENHIQDE | GVCSLAEGLK | KNSSLKILKL | SNNCITYLGA | KALLQALERN | DTILEVWLRG |
1030 | |||||
NIFSLEEVDK | LGCRDIRLLL |